Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ENFERMEDAD GRUPO REGISTRY PROYECTOS ENTRAR
 
 
  
Clinical characteristics-other -
--->Novedades
[-]El proyecto
--->Sponsor
--->[-]Comité Ejecutivo
--->Arnesen
--->Blumenstein
--->Burgunder
--->Craufurd
--->Humbert
--->Jones
--->Kremer
--->Reilmann
--->Roos
--->Rosser
--->Weydt
--->Capper-Loup
--->Feihle
--->Levey
--->McLean
--->Documentos públicos
--->[-]Writing Committee Strategic ...
--->Dates
--->[-]Comité Científico y Bioético
--->Becanovic
--->Busse
--->Frontali
--->Giorgini
--->Holmans
--->Mariotti
--->Norremolle
--->Reetz
--->Rickards
--->Saft
--->van Duijn
--->Valenza
--->Verellen
--->Documentos públicos
--->Coordinador central
--->Coordinadores locales
--->Fellowship Programme
--->[-]Constitución
--->Artículo 1
--->Artículo 2
--->Artículo 3
--->Artículo 4
--->Artículo 5
--->Artículo 6
--->Artículo 7
--->Artículo 8
--->Artículo 9
--->Artículo 10
--->Artículo 11
--->Artículo 12
--->Documentos
--->[-]Elecciones
--->[-]Miembros
--->Solicitud
[-]Centros
--->[+]Austria
--->[+]Bélgica
--->[+]República Checa
--->[+]Dinamarca
--->[+]Finlandia
--->[+]Francia
--->[+]Alemania
--->[+]Ireland
--->[+]Italia
--->[+]Países Bajos
--->[+]Noruega
--->[+]Polonia
--->[+]Portugal
--->[+]Rusia
--->[+]España
--->[+]Suecia
--->[+]Suiza
--->[+]Reino Unido
--->[+]Fuera de Europa
[-]Grupos de trabajo
--->[+]EH avanzada
--->[+]Fenotipo conductual
--->[+]Modificadores Biológicos
--->[+]Biomarcadores
--->[+]Banco de tejidos y cerebros...
--->[+]Fenotipo cognitivo
--->[+]Modificadores ambientales
--->[+]Evaluación Funcional
--->[+]Test y Consejo genético
--->[+]Genes Modificadores
--->[+]Economia de Salud
--->[+]Pruebas de imagen
--->[+]Huntington Juvenil
--->[+]Fenotipo motor
--->[+]Tratamiento Neuroprotector...
--->[+]Fisioterapia
--->[+]Calidad de vida
--->[-]Cuidados del paciente
--->[+]Acontecimientos
--->[+]Reuniones
--->[+]Dieticians
--->[+]SALT
--->[+]Dental care
--->[+]Occupational
--->[+]Tratamiento quirúrgico
--->[+]Tratamiento Sintomático
--->[+]Jóvenes
[-]Eventos
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Comunicación
--->¿Cómo contactar?
--->Forums
--->Listas de correos
--->Publicación
--->Ofertas de trabajo
fechadescripcióntamañoautor documento 
03.08.26A survey of dietary intake in patients with Huntington`s Disease32 kBanonymousapplication/mswordl03-survey-of-dietary-intake 
03.08.26Insulin sensitivity and early-phase insulin secretion in normoglycemic patients with Huntington’s Disease32 kBanonymousapplication/mswordl02-insulin-sensitivity-insulin-secret... 
03.08.26Sleep in patients with Huntington’s Disease: an interim analysis32 kBanonymousapplication/mswordl01-sleep-in-patients-with-hd 
03.08.26Assessing dysphagia in Huntington’s disease using Fiberoptic Endoscopic Evaluation of Swallowing (FEES)32 kBanonymousapplication/mswordl04-assessing-dysphagia-fees 
03.08.26Summary of carer's views of the decision to insert a percutaneous endoscopic gastrostomy (PEG) feeding tube32 kBanonymousapplication/mswordl05-summary-of-carers-views-peg 
03.08.26The Huntington’s Disease health-related Quality of Life questionnaire (HDQoL): Validation of a disease-specific measure of health-related quality of life32 kBanonymousapplication/mswordl09-validation-of-a-disease-specific-m... 
03.08.26Patient and proxy ratings using the Huntington’s Disease health-related Quality of Life questionnaire (HDQoL)32 kBanonymousapplication/mswordl08-patient-and-proxy-ratings-hdqol 
03.08.26Sexuality in Huntington´s Disease. Introducing a neuro-sexological viewpoint in bio-psycho-social rehabilitation32 kBanonymousapplication/mswordl06-sexuality-in-hd 
03.08.26Huntington's illness: the lived experience of Huntington's Disease32 kBanonymousapplication/mswordl10-the-lived-experience-of-hd 

Esta carpeta contiene 9 documentos.
about us | privacy statement | disclaimer | terms of use